Yes. The really great thing about this approach is you can use the click chemistry labelled antibody once, follow with 64Cu label to show that the antibody is targeted specifically to the tumour, then follow straight after with 67Cu label for the theranostic effect. You can ensure the antibody is working before exposing the patient to the dangerous radioisotope. If this approach works well in patients it will become a very valuable platform.
CU6 - Media and Industry News, page-163
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.14 |
Change
0.060(0.85%) |
Mkt cap ! $2.286B | |||
| Open | High | Low | Value | Volume |
| $7.18 | $7.30 | $6.96 | $5.748M | 804.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27982 | $7.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.22 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |